Independent clinical validation strengthens ABL’s leadership in the fast‑growing HIV drug‑resistance testing market ABL ...
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the life sciences tools & services stocks, including ...
Agilent Technologies, Inc. (NYSE:A) is one of the stocks on which Jim Cramer expressed his thoughts. A caller asked if the ...
A doctor-tech leader from India argues that genomic data infrastructure, resistance forecasting and sovereign AI discovery tools will be critical to future regional pandemic response.
The startup is developing AI foundation models trained on DNA rather than text or code, applying deep learning techniques to ...
Investor's Business Daily on MSN
Dow Jones futures fall as oil prices run past $90 on tanker attacks; Oracle, Nvidia lift these AI names
Stocks largely fell as crude oil prices jumped despite a record IEA reserves release amid the Iran war. Nvidia, Oracle news lifted AI stocks.
CLEVELAND, March 10, 2026 /PRNewswire/ -- GenomOncology, a leading precision medicine software company, today announced a strategic partnership with WeTrials, an AI-powered patient engagement and ...
Tempus AI's diagnostics arm is surging in 2025 as precision oncology testing, MRD adoption, AI-driven genomic tools and the Ambry Genetics acquisition expand capabilities.
Cathie Wood is a renowned investor. She has a long-term view, like Warren Buffett, but instead of investing in tried-and-true value stocks, Wood favors tech stocks that are disruptive innovators.
His job is to reimagine the future of drugmaking using that similarly trendy branch of computer science, artificial intelligence (AI). He is applying this to transferring as much of the load as ...
Temple is investigating the potential uses of artificial intelligence technology to increase revenue and optimize ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results